Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Asset Utilization Ratio (2017 - 2025)

Vistagen Therapeutics' Asset Utilization Ratio history spans 10 years, with the latest figure at 0.01 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 50.96% year-over-year to 0.01; the TTM value through Dec 2025 reached 0.01, up 50.96%, while the annual FY2025 figure was 0.0, N/A changed from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.01 at Vistagen Therapeutics, up from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.04 in Q3 2023 and bottomed at 0.01 in Q1 2025.
  • The 4-year median for Asset Utilization Ratio is 0.01 (2021), against an average of 0.01.
  • The largest annual shift saw Asset Utilization Ratio soared 58.32% in 2021 before it crashed 80.58% in 2024.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.02 in 2021, then fell by 9.07% to 0.01 in 2023, then plummeted by 50.19% to 0.01 in 2024, then soared by 50.96% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for VTGN's Asset Utilization Ratio are 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025).